Falsely elevated urinary ethanolamine levels due to vigabatrin.
Dooley
J
J
Department of Pediatrics (Neurology), Dalhousie University and IWK-Grace Health Centre, Halifax, Nova Scotia.
Gordon
K
K
Dooley
K
K
D000927:Anticonvulsants / Q000009:adverse effects*; D002675:Child, Preschool; D002658:Developmental Disabilities / Q000139:chemically induced*; D019856:Ethanolamine / Q000378:metabolism / Q000652:urine*; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D013036:Spasms, Infantile / Q000188:drug therapy*; D020888:Vigabatrin; D005680:gamma-Aminobutyric Acid / Q000009:adverse effects / Q000031:analogs & derivatives*
D000927:Anticonvulsants; D005680:gamma-Aminobutyric Acid; D019856:Ethanolamine; D020888:Vigabatrin